Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going forward but can stay intact. They think the fundamental backdrop is very…
The U.S. equity strategy team at UBS has a positive view on stocks heading into 2014, particularly technology, financials and industrials. Here are the names they feel have the absolute greatest chance…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, December 30, 2013.
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
courtesy of Apple Inc.Like most firms that we cover on Wall Street, Piper Jaffray has updated its top names to buy for 2014, and the firm has an extensive market commentary to…
ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing sector for the past three years, with year-to-date performance up 73%. Given…
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has been on fire, so much that two insiders decided to stuff their holiday stockings with about $23 million in stock sales. Chairman and CEO John Martin…
Jon C. Ogg ThinkstockThe DJIA has finally closed above 16,000 for the first time ever. With a light holiday week coming up and with year-end just around the corner, investors have to consider research ideas…
ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to…
ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies locally, but a new report from IMS Health shows that the total…
The Alpha Preference list of stocks to buy at UBS is comprised of companies that are the most preferred stocks to buy within the 41 major sectors that the firm covers. These…
ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%. Its trading volume of almost 9.2 million shares was almost eight-times the…
Jon OggWe are nearing the end of earnings season, and stocks have challenged new all-time highs. Now investors are starting to think about 2014, and the notion of which stocks to buy…
ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can be treated…
ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such, investors flock to the drug sector in times of uncertainty. But what…
